5 MG OF IV VITAMIN K IS SAFE AND EFFECTIVE TO REVERSE LIFE-THREATENING BLEEDS SECONDARY TO WARFARIN

被引：0
|
作者：
Ball, Emily [1 ]
Rech, Megan [1 ]
Lyons, Neal [1 ]
机构：
[1] Loyola Univ Med Ctr, Chicago, IL USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
780
引用
收藏
页码：381 / 381
页数：1
相关论文
共 22 条
  • [21] Rivaroxaban in long-term secondary prevention of VTE in patients with hereditary or acquired thrombophilia is as effective and safe as standard treatment with vitamin K antagonists
    Gerotziafas, G. T.
    Lefkou, E.
    Gkalea, V
    Spanoudaki, A.
    Ketatni, H.
    Evnorfiadis, I
    Elalamy, I
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 964 - 964
  • [22] Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: Insight from the AFTER-2 trial
    Aktan, Adem
    Guzel, Tuncay
    Aslan, Burhan
    Kilic, Raif
    Gunlu, Serhat
    Ozbek, Mehmet
    Arslan, Bayram
    Demir, Muhammed
    Ertas, Faruk
    [J]. KARDIOLOGIA POLSKA, 2023, 81 (02) : 132 - 140
123